China’s CATL tests EVs – and lithium’s dominance – with pioneering sodium-ion battery


Contemporary Amperex Technology (CATL) has deployed the world’s first sodium-ion batteries in passenger cars, as it aims to stay ahead in China’s fiercely competitive electric vehicle (EV) market amid price volatility in traditional lithium-ion batteries.

The company’s new Naxtra battery will be installed in China Changan Automobile Group EVs this week for winter testing in the chilly Inner Mongolia autonomous region in the country’s north.

“The breakthroughs in sodium-ion technology bring greater resilience, a wider operating temperature range and more sustainable growth to electrification,” said Gao Huan, chief technology officer at the battery giant, at a press conference on Thursday.

Under an agreement between the two companies, Changan will start using CATL’s sodium-ion batteries across its entire brand portfolio – comprising the Avatr, Deepal, Qiyuan and Uni models.

Changan’s chief brand officer Tan Benhong said the firm would accelerate the application of sodium-ion batteries, as the state-managed carmaker echoed China’s national strategy of bringing safe, economical and durable EVs to more people.

CATL’s new Naxtra battery will be installed in China Changan Automobile Group EVs this week for winter testing in the Inner Mongolia autonomous region. Photo: Weibo
CATL’s new Naxtra battery will be installed in China Changan Automobile Group EVs this week for winter testing in the Inner Mongolia autonomous region. Photo: Weibo

The carmaker would also test its Avatr 12 model in Antarctica within the next 18 months, making it the first EV sedan to drive on the frozen continent, Tan said.

  • Related Posts

    With Meta-Manus AI deal ‘difficult’ to undo, how will Beijing exert its authority?

    It could be “time-consuming”, “complex” and “difficult” for Meta Platforms to unwind its acquisition of Manus, an artificial intelligence start-up that originated in China, given how far the deal has…

    Continue reading
    WuXi AppTec shares surge 14% in Hong Kong after record first-quarter earnings

    Shares of WuXi AppTec surged both on the mainland and in Hong Kong after stronger-than-expected quarterly results lifted sentiment across the contract research and innovative drug sectors. The pharmaceutical company’s…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *